To investigate the safety and pharmacokinetics of intravenous SLV338

• Research type

  Research Study

• Full title

  A Placebo-Controlled, Combined Single and Multiple Rising Dose Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SLV338 after Intravenous Dosing in Healthy Male Subjects

• IRAS ID

  17412

• Sponsor organisation

  Solvay Pharmaceuticals BV.

• Eudract number

  2008-006753-40

• ISRCTN Number

  No number provided

• Clinicaltrials.gov Identifier

  No number provided

• Research summary

  Research Summary not published at request of researcher

• REC name

  London - London Bridge Research Ethics Committee

• REC reference

  09/H0804/19

• Date of REC Opinion

  21 Apr 2009

• REC opinion

  Further Information Favourable Opinion